𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ropinirole in the Treatment of Patients With Restless Legs Syndrome: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial

✍ Scribed by Bogan, Richard K.; Fry, June M.; Schmidt, Markus H.; Carson, Stanley W.; Ritchie, Sally Y.

Book ID
122603139
Publisher
Mayo Clinic
Year
2006
Tongue
English
Weight
164 KB
Volume
81
Category
Article
ISSN
0025-6196

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rotigotine improves restless legs syndro
Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States
✍ Wayne A. Hening; Richard P. Allen; William G. Ondo; Arthur S. Walters; John W. W πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 229 KB πŸ‘ 1 views

## Abstract This randomized, double‐blinded, placebo‐controlled trial (NCT00135993) assessed efficacy and safety of the dopamine agonist rotigotine in the treatment of idiopathic restless legs syndrome (RLS) over a 6‐month maintenance period. A total of 505 eligible participants with moderate to se

Ropinirole is effective in the treatment
Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study
✍ Arthur S. Walters; William G. Ondo; Tilman Dreykluft; Ron Grunstein; Daniel Lee; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 181 KB πŸ‘ 1 views

## Abstract Restless legs syndrome (RLS) is a neurological condition with significant impact on sleep and quality of life (QoL). This double‐blind, randomized, 12‐week, multinational study compared the efficacy and safety of ropinirole and placebo in RLS. In total, 267 outpatients with moderate‐to‐